These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues. Hayashi Y, Widjono YW, Ohta K, Hanioka K, Obayashi C, Itoh K, Imai Y, Itoh H. Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978 [Abstract] [Full Text] [Related]
3. Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2,p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma. Sun XF, Carstensen JM, Stål O, Zhang H, Nordenskjöld B. Int J Cancer; 1996 Feb 20; 69(1):5-8. PubMed ID: 8600060 [Abstract] [Full Text] [Related]
5. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers. Akkiprik M, Ataizi-Celikel C, Düşünceli F, Sönmez O, Gulluoglu BM, Sav A, Ozer A. J Gastrointestin Liver Dis; 2007 Mar 20; 16(1):11-7. PubMed ID: 17410283 [Abstract] [Full Text] [Related]
6. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma. Georgescu CV, Săftoiu A, Georgescu CC, Ciurea R, Ciurea T. J Gastrointestin Liver Dis; 2007 Jun 20; 16(2):133-9. PubMed ID: 17592558 [Abstract] [Full Text] [Related]
7. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma. Ikeda S, Shimizu Y, Fujimori M, Ishizaki Y, Kurihara T, Ojima Y, Okajima M, Asahara T. Clin Cancer Res; 2003 Nov 15; 9(15):5660-5. PubMed ID: 14654549 [Abstract] [Full Text] [Related]
8. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices. Ioachim EE, Goussia AC, Machera M, Tsianos EV, Kappas AM, Agnantis NJ. Anticancer Res; 1999 Nov 15; 19(3A):2147-55. PubMed ID: 10470163 [Abstract] [Full Text] [Related]
9. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT. Am J Surg Pathol; 2016 Mar 15; 40(3):419-32. PubMed ID: 26551622 [Abstract] [Full Text] [Related]
10. [P53 protein in adenocarcinoma of the large intestine]. Paluszkiewicz P, Pawłowska-Wakowicz B, Cybulski M, Berbeć H. Wiad Lek; 1997 Mar 15; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410 [Abstract] [Full Text] [Related]
13. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach. Tornillo L, Lugli A, Zlobec I, Willi N, Glatz K, Lehmann F, Spichtin HP, Maurer R, Stoios D, Sauter G, Terracciano L. Am J Clin Pathol; 2007 Jan 15; 127(1):114-23. PubMed ID: 17145638 [Abstract] [Full Text] [Related]
14. Relationship among p53, stage, and prognosis of large bowel cancer. Nathanson SD, Linden MD, Tender P, Zarbo RJ, Jacobsen G, Nelson LT. Dis Colon Rectum; 1994 Jun 15; 37(6):527-34. PubMed ID: 8200229 [Abstract] [Full Text] [Related]
15. Colorectal adenocarcinoma as a second malignant neoplasm following rhabdomyosarcoma of the urinary bladder: a case report. Park SS, Kim BK, Kim CJ, Kim WS, Kim IO, Park KW, Shin HY, Ahn HS. J Korean Med Sci; 2000 Aug 15; 15(4):475-7. PubMed ID: 10983702 [Abstract] [Full Text] [Related]
18. Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum. Zhang H, Evertsson S, Sun X. Int J Oncol; 1999 Jun 15; 14(6):1057-61. PubMed ID: 10339657 [Abstract] [Full Text] [Related]